Brief: Lansen Pharmaceutical Holdings Group Sees Noticeable Decrease In FY Net Profit
25/01/2019 10:34
Jan 25 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* GROUP EXPECTS TO RECORD A NOTICEABLE DECREASE IN ITS NET
PROFIT
FOR YEAR ENDED 31 DECEMBER 2018
* EXPECTED RESULT DUE TO ABSENCE OF AN ONE-OFF INCOME FROM
INSURANCE CLAIMS FOR FLOOD IN YEAR ENDED 31 DECEMBER 2017
Source text for Eikon: ID:nHKS897Syd
Further company coverage: 0503.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year